School of Medicine
Showing 71-80 of 89 Results
-
Jay Shah
Associate Professor of Urology
BioDr. Jay Shah, MD is a staff surgeon and associate professor of Urology at Stanford University. He is also the Cancer Care Program Leader for Urologic Oncology at the Stanford Cancer Center. He is widely respected for his work on optimizing outcomes after surgery for bladder cancer and he lectures internationally on this topic. He is a graduate of the American Urological Association Leadership Academy and he sits on multiple national AUA committees. With a deep interest in quality improvement work, Dr. Shah is the Physician Improvement Leader for the Stanford Department of Urology and a Medical Director of the Stanford Realizing Improvement Through Empowerment (RITE) Program. Since joining the Stanford faculty in February 2017, Dr. Shah has successfully completed the Clinical Effectiveness Leadership Training (CELT) Program, the Stanford Leadership Development Program, and the Stanford Medicine Leadership Academy. His vision is to have Stanford Medicine become known for instilling leadership in all of our faculty and trainees. With this goal in mind, he has started an accredited fellowship training program in Urologic Oncology and a QI/leadership training program for urology residents. He also lectures internationally on leadership development, team building, and quality improvement.
Dr. Shah graduated magna cum laude with a degree in Biological Sciences from Harvard College. He obtained his medical degree and completed his urology residency training at Columbia University. During his time at Columbia, Dr. Shah was elected to the Alpha Omega Alpha Medical Honor Society; he was named Physician of the Year by the nursing staff; and he was recognized by the medical students with the Gold Foundation Excellence in Teaching Award. After residency, he completed a three-year fellowship in Urologic Oncology at MD Anderson Cancer Center where he earned a coveted faculty position. During his time as faculty at MD Anderson, Dr. Shah launched the bladder cancer robotics program, developed an enhanced recovery program for patients undergoing bladder removal surgery, became double board-certified in Urology and Medical Quality, and was chosen to lead the MDACC Genitourinary Center as Center Medical Director.
In his free time, Dr. Shah enjoys reading, cooking, surfing, hiking and exploring the beaches of Northern California in his Jeep Wrangler with his family and 2 dogs. -
Eugene Shkolyar, MD
Clinical Assistant Professor, Urology
BioEugene Shkolyar, MD is a urologic oncologist who specializes in treating patients with bladder, prostate, kidney, and testis cancers. He is a clinical assistant professor in the Department of Urology at the Stanford School of Medicine.
Dr. Shkolyar has expertise in open, endoscopic, and robotic surgery and in caring for patients with complex urologic oncology needs. Dr. Shkolyar is actively engaged in translational research, with a particular interest in integrating artificial intelligence into bladder cancer treatment and the development of novel biomarkers for cancer detection. His commitment to continual innovation ensures that his patients have access to the latest and most effective treatment options.
Dr. Shkolyar was born in Kyiv, Ukraine, and raised in New York. He attended Cornell University for his undergraduate education and went on to UCLA for medical school. Following medical school, Dr. Shkolyar completed a residency in urology at Stanford, where he developed his interest in urologic oncology, translational bladder cancer research and teaching. He went on to complete a two-year fellowship in urologic oncology at Stanford School of Medicine gaining additional skills in management of complex urologic cancers. Dr. Shkolyar is the recipient of numerous honors and awards, including membership in the Alpha Omega Alpha medical honors society and a research scholar award from the Urology Care Foundation. In addition, he has authored and co-authored numerous publications in urology, artificial intelligence, and device development.
Dr. Shkolyar is a member of the Society of Urologic Oncology, the American Society of Clinical Oncology, the American Urological Association, and the European Association of Urology. -
Linda M. Dairiki Shortliffe
Stanley McCormick Memorial Professor in the School of Medicine, Emerita
Current Research and Scholarly InterestsThe timing for intervention in obstruction in the infant and child is poorly understood.Our group has been interested in trying to define the risks that may be involved in obstructive and infectious uropathies and discovering early signs of damage to the urinary tract and kidney. We have explored ways of imaging the urinary tract using nonionizing radiation (US, MRI). We have studied the relationships of sex steroid hormones, pregnancy, reflux, urinary tract infection and urinary tract function.
-
Eila C. Skinner
Thomas A. Stamey Research Professor of Urology
Current Research and Scholarly InterestsMy research focuses on outcomes in the treatment of muscle invasive and high-grade non-muscle invasive bladder cancer. This includes identifying markers of prognosis, predictive markers for response to surgery and chemotherapy, and working toward an individualized, multidisciplinary approach to disease management. I have also focused on optimizing the use of lower urinary tract reconstruction in patients undergoing cystectomy, and developing interventions to improve patient quality of life.
-
Eric R. Sokol, MD
Associate Professor of Obstetrics and Gynecology (Gynecology-Urogynecology) and, by courtesy, of Urology
Current Research and Scholarly InterestsMy research is focused on the development and testing of novel minimally invasive treatment modalities for complex pelvic floor disorders.
-
Geoffrey Sonn
Associate Professor of Urology and, by courtesy, of Radiology (Body MRI)
Current Research and Scholarly InterestsMy interest is in improving prostate cancer diagnosis through MRI and image-targeted prostate biopsy. In collaboration with radiologists at Stanford, we are working to define the optimal role of MRI in prostate cancer. We hope to improve cancer imaging to the point that some men with elevated PSA may safely avoid prostate biopsy. For those who need biopsy, we are evaluating novel MRI-US fusion targeted biopsy, a technique that greatly improves upon the conventional biopsy method.
-
Sandy Srinivas
Professor of Medicine (Oncology) and, by courtesy, of Urology
Current Research and Scholarly InterestsClinical interests: general oncology, genito-urinary malignancy Research interests: conducting clinical trials in advanced prostate cancer, bladder cancer and renal cell carcinoma
-
Leslee L.Subak, MD
Katharine Dexter McCormick and Stanley McCormick Memorial Professor and Professor, by courtesy, of Urology
Current Research and Scholarly InterestsMy research focuses on the association of weight and urinary incontinence (UI) in women and clinical trials to test strategies to improve outcomes in women’s genitourinary health. We have shown the independent association of weight and UI and the efficacy of weight loss to treat women with UI. I also conduct studies of epidemiology, economics and cost-effectiveness, and novel interventions for UI, sexual dysfunction, vaginal atrophy, pelvic organ prolapse and menopause symptoms.
-
Ryan R. Sun
Clinical Assistant Professor, Urology
BioDr. Sun is a board-eligible, fellowship-trained urologist specializing in general urology and endourology. He is a clinical assistant professor of urology at Stanford University School of Medicine. He graduated with Cum Laud from the University of Washington and obtained his medical degree from the University of Toronto. After completing his urology residency at the University of Manitoba, Dr. Sun completed further fellowship training in Endourology at Stanford University School of Medicine.
Dr. Sun speaks fluent Mandarin and sees patients with a wide spectrum of general urologic diseases of the kidneys, bladder, prostate, and genitalia, with a special focus in complex kidney stone disease and minimally invasive surgery. He has received multiple research awards and authored numerous peer-reviewed publications regarding kidney stone disease, oncology, education, imaging, voiding dysfunction, and gene therapy.
In his academic role, Dr. Sun is committed to providing compassionate care and developing innovative treatments to advance minimally invasive surgical techniques.
